403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Biopharma PEG Expands DSPE-Based PEG Lipid Portfolio for LNP and Drug Delivery Research
(MENAFN- Biopharma PEG Scientific Inc.) Watertown, MA, USA – August 31, 2026 — Biopharma PEG Scientific Inc., a supplier of PEG derivatives and PEG-based materials for pharmaceutical and biotechnology research, has expanded its portfolio of DSPE and DSPE-based PEG lipids for lipid nanoparticle (LNP), liposome, drug delivery, and bioconjugation research.
The portfolio includes DSPE (CAS No. 1069-79-0), mPEG-DSPE, DSPE-PEG-NH₂, DSPE-PEG-Mal, DSPE-PEG-Mannose, and DSPE-PEG-c(RGDyk), providing researchers with a range of lipid-PEG structures and functional groups for formulation development and surface engineering.
DSPE and Functionalized DSPE-PEG Lipids
DSPE is a widely used phospholipid building block in lipid-based drug delivery systems. When combined with PEG and functional terminal groups, DSPE-PEG derivatives can provide additional options for nanoparticle surface modification, PEGylation, ligand attachment, and targeted delivery research.
Biopharma PEG's current portfolio includes:
DSPE, CAS No. 1069-79-0 — phospholipid building block; kg-scale stock available
mPEG-DSPE — available in multiple molecular weights, including 1K, 2K, 3.4K, 5K, 10K, 20K, and 40K
DSPE-PEG-NH₂ — amine-functionalized PEG lipid for conjugation and surface modification
DSPE-PEG-Mal — maleimide-functionalized PEG lipid for thiol conjugation
DSPE-PEG-Mannose — mannose-functionalized PEG lipid for targeted delivery research
DSPE-PEG-c(RGDyk) — cyclic RGD-functionalized PEG lipid for integrin-targeting research
DSPE-PEG materials are used in research involving liposomes, lipid nanoparticles, targeted drug delivery, and other functionalized lipid systems. Biopharma PEG provides different PEG molecular weights and terminal functionalities to support diverse formulation and conjugation strategies.
Supporting Research from Development to Scale-Up
In addition to standard PEG lipids, Biopharma PEG provides custom PEG derivative synthesis and PEG materials for research and larger-scale development. The company offers monodispersed and polydispersed PEG derivatives, with capabilities extending from gram quantities to larger-scale production.
The DSPE-based portfolio complements Biopharma PEG's broader range of PEG lipids and delivery-related materials, supporting research programs in mRNA delivery, LNP formulation, liposomes, targeted nanoparticles, PEGylation, and bioconjugation.
Researchers can explore product specifications, available molecular weights, and current product information through the company's online catalog.
Address: 108 Water Street, Suite 4D, Watertown, MA 02472, USA
Email: ...
Website:
The portfolio includes DSPE (CAS No. 1069-79-0), mPEG-DSPE, DSPE-PEG-NH₂, DSPE-PEG-Mal, DSPE-PEG-Mannose, and DSPE-PEG-c(RGDyk), providing researchers with a range of lipid-PEG structures and functional groups for formulation development and surface engineering.
DSPE and Functionalized DSPE-PEG Lipids
DSPE is a widely used phospholipid building block in lipid-based drug delivery systems. When combined with PEG and functional terminal groups, DSPE-PEG derivatives can provide additional options for nanoparticle surface modification, PEGylation, ligand attachment, and targeted delivery research.
Biopharma PEG's current portfolio includes:
DSPE, CAS No. 1069-79-0 — phospholipid building block; kg-scale stock available
mPEG-DSPE — available in multiple molecular weights, including 1K, 2K, 3.4K, 5K, 10K, 20K, and 40K
DSPE-PEG-NH₂ — amine-functionalized PEG lipid for conjugation and surface modification
DSPE-PEG-Mal — maleimide-functionalized PEG lipid for thiol conjugation
DSPE-PEG-Mannose — mannose-functionalized PEG lipid for targeted delivery research
DSPE-PEG-c(RGDyk) — cyclic RGD-functionalized PEG lipid for integrin-targeting research
DSPE-PEG materials are used in research involving liposomes, lipid nanoparticles, targeted drug delivery, and other functionalized lipid systems. Biopharma PEG provides different PEG molecular weights and terminal functionalities to support diverse formulation and conjugation strategies.
Supporting Research from Development to Scale-Up
In addition to standard PEG lipids, Biopharma PEG provides custom PEG derivative synthesis and PEG materials for research and larger-scale development. The company offers monodispersed and polydispersed PEG derivatives, with capabilities extending from gram quantities to larger-scale production.
The DSPE-based portfolio complements Biopharma PEG's broader range of PEG lipids and delivery-related materials, supporting research programs in mRNA delivery, LNP formulation, liposomes, targeted nanoparticles, PEGylation, and bioconjugation.
Researchers can explore product specifications, available molecular weights, and current product information through the company's online catalog.
Address: 108 Water Street, Suite 4D, Watertown, MA 02472, USA
Email: ...
Website:
Biopharma PEG Scientific Inc.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment